ABSTRACT
Objective To compare the clinical value of cardiac magnetic resonance (CMR)and echocardiography in diagnosis of hypertrophic cardiomyopathy (HCM).Methods 3 6 patients with HCM diagnosed clinically underwent CMR examination,and then compared with the results of echocardiography.Results 36 cases of HCM were all detected by CMR,including 15 cases of ventricular-septal HCM,5 cases of diffuse HCM,4 cases of midventricular HCM,2 cases of anterior-wall HCM and 10 cases of apical HCM.In addition,12 cases were performed enhanced-CMR scanning,and myocardial ischemia was showed in 4 cases and myocardial fibrosis in 5 cases.1 3 cases of ventricular-septal HCM,5 cases of diffuse HCM,3 cases of midventricular HCM and 1 cases of anterior-wall HCM were detected by echocardiography respectively(22/26).There was no significant difference between echocardiography and CMR(26/26)(P＞0.05).However, only 3 cases of apical HCM were detected by echocardiography (3/10)definitlely,and there was statistically significant difference between echocardiography and CMR(10/10)(P＜0.05).Additionally,on CMR theleft ventricular ejection fraction(EF)in all patients [(58.24±3.24)%] was significantly lower than the results of echocardiography [(71.20±6.24)%]and the left ventricular mass (LVM)[(126.54±36.42)g/m2 ]was higher than echocardiography [(84.54±36.42)g/m2 ],and the mean EF and LVM value had a significant difference between echocardiography and CMR (P＜0.05).Conclusion CMR imaging is superior to echocardiography in the diagnosis of HCM and evaluation of cardiac function,especially in the apical HCM.In addition,myocardial perfusion and delayed-enhanced imaging can effectively assess myocardial perfusion and viability in HCM.
ABSTRACT
can specifically combined with EGFR, which may be applied to noninvasive NIRF imaging of tumors highly expressed EGFR in vivo.